Competitor accuses 23andMe of ‘false negatives’ in cancer-gene testing
GABE GINSBERG/GETTY IMAGES FOR LARAS
In a new study, Invitae concludes that in some ethnic groups the chance that 23andMe's tests will miss a cancer-causing DNA variant is 100%.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario